Immunohistochemical biomarkers are prognostic relevant in addition to the ESMO-ESGO-ESTRO risk classification in endometrial cancer

Loading...
Thumbnail Image
Date
2021
Authors
Vrede, S. W.
Van Weelden, Willem Jan
Visser, N. C. M.
Bulten, Johan
van der Putten, Louis J. M.
van de Vijver, Koen
Santacana Espasa, Maria
Colàs Campàs, LauraColàs Campàs, Laura - ORCID ID
Gil-Moreno, Antonio
Moiola, Cristian P.
Other authors
Impact
Export
Share
Journal Title
Journal ISSN
Volume Title
Related resource
Citation
Journal or Serie
Gynecologic Oncology, 2021, vol. 161, núm. 3, p. 787-794